278 related articles for article (PubMed ID: 34821673)
1. Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes-Findings from a Large UK Centre.
Lee K; Gunasinghe S; Chapman A; Findlow LA; Hyland J; Ohol S; Urwin A; Rutter MK; Schofield J; Thabit H; Leelarathna L
Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821673
[TBL] [Abstract][Full Text] [Related]
2. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
[TBL] [Abstract][Full Text] [Related]
3. Real-world glycaemic outcomes in patients with type 1 diabetes using glucose sensors-Experience from a single centre in Dublin.
Lyons RE; Abdul Wahab R; Goh SY; Breen C; Rhynehart A; O'Scannail M; Kelly HJ; Neff K; O'Shea D; Canavan R; Wan Mahmood WA
Endocrinol Diabetes Metab; 2024 Jan; 7(1):e469. PubMed ID: 38268307
[TBL] [Abstract][Full Text] [Related]
4. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
5. Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital.
Courtney A; Smith D; Forde H
Ir J Med Sci; 2023 Dec; 192(6):2763-2768. PubMed ID: 36940009
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
[TBL] [Abstract][Full Text] [Related]
7. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
Reddy M; Jugnee N; Anantharaja S; Oliver N
Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR
Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Uhl S; Choure A; Rouse B; Loblack A; Reaven P
J Clin Endocrinol Metab; 2024 Mar; 109(4):1119-1131. PubMed ID: 37987208
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT-CGM system in Germany, Sweden and the United Kingdom (2018-2020).
Acciaroli G; van der Linden J; Chao C; Walker TC; Oliver N
Diabet Med; 2023 Feb; 40(2):e14946. PubMed ID: 36053809
[TBL] [Abstract][Full Text] [Related]
11. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia.
Isitt JJ; Roze S; Tilden D; Arora N; Palmer AJ; Jones T; Rentoul D; Lynch P
Diabet Med; 2022 Jul; 39(7):e14831. PubMed ID: 35298036
[TBL] [Abstract][Full Text] [Related]
12. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
Brown RE; Chu L; Norman GJ; Abitbol A
Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
[TBL] [Abstract][Full Text] [Related]
13. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).
Fokkert M; van Dijk P; Edens M; Barents E; Mollema J; Slingerland R; Gans R; Bilo H
BMJ Open Diabetes Res Care; 2019; 7(1):e000809. PubMed ID: 31875133
[TBL] [Abstract][Full Text] [Related]
14. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
15. Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5).
Lameijer A; Fokkert MJ; Edens MA; Slingerland RJ; Bilo HJG; van Dijk PR
J Clin Transl Endocrinol; 2020 Dec; 22():100237. PubMed ID: 33102135
[TBL] [Abstract][Full Text] [Related]
16. A pragmatic real-life study of flash glucose monitoring versus self-monitoring of blood glucose.
Greve SV; Stilgren L
Dan Med J; 2020 Jun; 67(6):. PubMed ID: 32741434
[TBL] [Abstract][Full Text] [Related]
17. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
Turner LV; Marak MC; Gal RL; Calhoun P; Li Z; Jacobs PG; Clements MA; Martin CK; Doyle FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR; Riddell MC;
Diabetologia; 2024 Jun; 67(6):1009-1022. PubMed ID: 38502241
[TBL] [Abstract][Full Text] [Related]
18. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
[TBL] [Abstract][Full Text] [Related]
19. A head-to-head comparison between Guardian Connect and FreeStyle Libre systems and an evaluation of user acceptability of sensors in patients with type 1 diabetes.
Yeoh E; Png D; Khoo J; Chee YJ; Sharda P; Low S; Lim SC; Subramaniam T
Diabetes Metab Res Rev; 2022 Oct; 38(7):e3560. PubMed ID: 35728796
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
